INCA Article in Journal of Neuroendocrinology Was Certified Within Top 10% Most Read Papers
In April 2025, the Journal of Neuroendocrinology, on behalf of British Society for Neuroendocrinology, informed that the INCA article “Global challenges in access to diagnostics and treatment for neuroendocrine tumor (NET) patients” was ranked within the top 10% of...
INCA Annual General Meeting 2025 Elected President-Elect and Board Members
On April 3rd, 2025, the INCA Annual General Meeting (AGM) 2025 convened the full INCA Membership to reflect on the reported achievements in 2024 and build on priorities and plans going forward. Four candidates were re-elected to continue serving on the INCA Board of...
INCA Brought the Patient Perspective on Equal Care in EU at the ESMO Sarcoma and Rare Cancers Congress
The ESMO Sarcoma and Rare Cancers Congress 2025 was held from 20–22 March in Lugano, Switzerland, gathering the latest on groundbreaking research and innovative treatments in this oncology field. INCA was represented by Catherine Bouvier-Ellis, INCA Advocacy Committee...
INCA Is Hosting Neuroendocrine Tumor Educational Event for Patients and Caregivers in Mexico on February 14th, 2025
INCA is hosting an in-person Neuroendocrine Tumor Educational Event for patients and caregivers in Mexico City on Friday, February 14th, 2025, from 9 am to 2.30 pm. Hear presentations from local experts and stories from those in the neuroendocrine tumor (NET or...
The 2025 Annual INCA/ENETS Symposium Will Highlight Ways to Improve NEN Research Globally
The traditional annual INCA/ENETS Symposium will take place during the 22nd Annual ENETS Conference in Krakow, Poland, on March 6th, 2025, from 16:15 – 17:45 CET. The long-standing collaboration between NEN patient advocates and NEN experts will be upgraded this...
INCA is a non-profit 501(c)3 organization incorporated in 2013.
